145 related articles for article (PubMed ID: 21881455)
1. A self-limiting case of atypical neuroleptic malignant syndrome associated with zotepine.
Hsu WC; Lin ST; Chen CC; Tsang HY; Huang MF
J Clin Psychopharmacol; 2011 Oct; 31(5):667-9. PubMed ID: 21881455
[No Abstract] [Full Text] [Related]
2. Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome.
Tsai JH; Yang P; Yen JY; Chen CC; Yang MJ
Pharmacotherapy; 2005 Aug; 25(8):1156-9. PubMed ID: 16207109
[TBL] [Abstract][Full Text] [Related]
3. [Zotepine versus perazine in patients with paranoid schizophrenia: a double-blind controlled trial of its effectiveness].
Wetzel H; von Bardeleben U; Holsboer F; Benkert O
Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():23-9. PubMed ID: 1683336
[TBL] [Abstract][Full Text] [Related]
4. Zotepine-induced convulsion at a low dose in a case of paranoid schizophrenia.
Ali M; Das S
Psychiatry Clin Neurosci; 2018 May; 72(5):374. PubMed ID: 29363876
[No Abstract] [Full Text] [Related]
5. Clozapine-induced neuroleptic malignant syndrome: clozapine monotherapy rechallenge in a case of previous NMS.
Illing M; Ancill R
Can J Psychiatry; 1996 May; 41(4):258. PubMed ID: 8726793
[No Abstract] [Full Text] [Related]
6. [Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind study].
Fleischhacker WW; Barnas C; Stuppäck CH; Sperner-Unterweger B; Miller C; Hinterhuber H
Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():10-3. PubMed ID: 1683332
[TBL] [Abstract][Full Text] [Related]
7. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
Mall GD; Hake L; Benjamin AB; Adityanjee A
J Clin Psychopharmacol; 2008 Oct; 28(5):572-3. PubMed ID: 18794658
[No Abstract] [Full Text] [Related]
8. [Neuroleptic malignant syndrome--a case report].
Lanczik M; Fritze J
Psychiatr Prax; 1992 May; 19(3):84-6. PubMed ID: 1353269
[TBL] [Abstract][Full Text] [Related]
9. [The risperidone-associated neuroleptic malignant syndrome in a pediatric patient].
Villanueva Lamas J; García García J; Alda Diez JA; Tous Andreu N
An Esp Pediatr; 1998 Dec; 49(6):652-3. PubMed ID: 9972639
[No Abstract] [Full Text] [Related]
10. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
Liu PY; Wu PC; Chen CY; Chen YC
Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
[TBL] [Abstract][Full Text] [Related]
11. Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal.
Tanii H; Fujita K; Okazaki Y
Am J Psychiatry; 2006 Mar; 163(3):547-8. PubMed ID: 16513884
[No Abstract] [Full Text] [Related]
12. Zotepine, a neuroleptic drug with a bipolar therapeutic profile.
Dieterle DM; Ackenheil M; Müller-Spahn F; Kapfhammer HP
Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):52-7. PubMed ID: 2883683
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with the neuroleptic zotepine--first results.
Haug HJ
Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):35-7. PubMed ID: 2883679
[TBL] [Abstract][Full Text] [Related]
14. Paliperidone-associated atypical neuroleptic malignant syndrome: a case report.
Han C; Lee SJ; Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):650-1. PubMed ID: 21163319
[No Abstract] [Full Text] [Related]
15. Clinical and EEG studies of zotepine, a thiepine neuroleptic, on schizophrenic patients.
Higashi Y; Momotani Y; Suzuki E; Kaku T
Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):8-11. PubMed ID: 2883687
[TBL] [Abstract][Full Text] [Related]
16. Olanzapine-induced neuroleptic malignant syndrome.
Burkhard PR; Vingerhoets FJ; Alberque C; Landis T
Arch Gen Psychiatry; 1999 Jan; 56(1):101-2. PubMed ID: 9892264
[No Abstract] [Full Text] [Related]
17. [Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol].
Barnas C; Stuppäck CH; Miller C; Haring C; Sperner-Unterweger B; Fleischhacker WW
Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():36-40. PubMed ID: 1683338
[TBL] [Abstract][Full Text] [Related]
18. [A case of malignant neuroleptic syndrome with rhabdomyolysis and a therapeutic trial using physostigmine].
Krull F; Risse A
Fortschr Neurol Psychiatr; 1986 Dec; 54(12):398-401. PubMed ID: 2880787
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic Malignant syndrome (NMS): a rare presentation induced by an antiemetic - case report.
Kashyap GL; Patel AG
Psychiatr Danub; 2011 Sep; 23 Suppl 1():S43-5. PubMed ID: 21894101
[TBL] [Abstract][Full Text] [Related]
20. Rifampin-zotepine interaction reduces effectiveness of antipsychotic drugs in a stable schizophrenia patient.
Pai MS; Yang SN; Shiah IS
Psychiatry Clin Neurosci; 2012 Oct; 66(6):538. PubMed ID: 23066778
[No Abstract] [Full Text] [Related]
[Next] [New Search]
